IDiyas

For the Inventor, By the Inventor

Oss, Netherlands

Aduro Biotech Holdings, Europe B.v.


USPTO Granted Patents = 12



Forward Citations = 54

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Hans Van Eenennaam (12 out of 17 patents)

silverMedal Andrea Van Elsas (11 out of 19 patents)

bronzeMedal Jan Paul Medema (7 out of 10 patents)

4.  David Lutje Hulsik (7 out of 7 patents)

5.  Lilian Driessen (3 out of 3 patents)

6.  Paul Vink (2 out of 2 patents)

7.  Joost Kreijtz (2 out of 2 patents)

8.  Erik Voets (1 out of 1 patent)

9.  Carlos Ricardo Rodrigues Dos Reis (1 out of 1 patent)

10.  Winfried Robert Mulder (1 out of 1 patent)

11.  Jannetje Geertruida Borst (1 out of 2 patents)

12.  Aartje Maria Elizabeth Veraar (1 out of 1 patent)

13.  Paul Maria Frederikus Vink (1 out of 1 patent)

14.  Uyen Truong Phan (0 patent)

15.  Jan Paul Medema (0 patent)


12 patents:

1. 12168693 - Combining CD27 agonists and immune checkpoint inhibition for immune stimulation (2024-12-17),
2. 12145992 - Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) protein (2024-11-19),
3. 11959924 - Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sample (2024-04-16),
4. 11047864 - Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sample (2021-06-29),
5. 10961316 - Humanized antibodies which bind to human APRIL ('a proliferation-inducing ligand') (2021-03-30),
6. 10851164 - Anti-SIRPα antibodies (2020-12-01),
7. 10808030 - Anti-HCTLA-4 antibodies (2020-10-20),
8. 10494436 - Anti-PD-1 antibodies (2019-12-03),
9. 10377830 - Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies (2019-08-13),
10. 10107821 - Proliferation-inducing ligand (APRIL)-binding peptides (2018-10-23),
11. 9969808 - Altered APRIL binding antibodies (2018-05-15),
12. 9527916 - Agonistic antibody to CD27 (2016-12-27),
Aduro Biotech Holdings, Europe B.v. is a biotechnology company focused on developing novel immunotherapies for cancer. With a strong pipeline of innovative treatments, Aduro aims to revolutionize the way cancer is treated and improve patient outcomes. Through cutting-edge research and strategic partnerships, Aduro is committed to making a meaningful impact in the fight against cancer.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

12 Patents

#5 in Oss

#534 in Netherlands

#46,630 in the World

...
Oss, Netherlands

Aduro Biotech Holdings, Europe B.v.

Forward Citations = 54

40 inventors:

goldMedal Hans Van Eenennaam (12 out of 17 patents)

silverMedal Andrea Van Elsas (11 out of 19 patents)

bronzeMedal Jan Paul Medema (7 out of 10 patents)

4.  David Lutje Hulsik (7 out of 7 patents)

5.  Lilian Driessen (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…